Memorandum from NZSG

Posted Thursday April 6, 2023

The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website

Gallery

Related Articles

Achieve Lasting Remission in IBD with Stelera

Thursday November 14, 2024

Pharma News

Read more »

President’s Update

Thursday October 17, 2024

News

Read more »

Blackcurrants – valuable prebiotics to support gut function.

Monday September 30, 2024

We have several packs of CurraNZ to give away at NZSG-NZgNC ASM. Come see us at the NPO lounge in the exhibition hall to...

Pharma News

Read more »